Centrexion Therapeutics
Centrexion Therapeutics is a late clinical-stage biopharmaceutical company headquartered at One Boston Place, Suite 3520, Boston, Massachusetts, developing novel non-opioid, non-addictive therapies for chronic pain alongside an emerging portfolio in immunology and inflammation. The company was founded by Sol Barer, Ph.D. — a founder of Celgene, who chairs the board — and by James N. Campbell, M.D., president and chief scientific officer and Professor Emeritus of neurosurgery at Johns Hopkins University School of Medicine. Jeffrey B. Kindler, formerly chief executive of Pfizer, joined as chief executive officer in 2013. Its lead asset, CNTX-4975, is a highly purified synthetic trans-capsaicin injected directly into the painful joint that produces analgesia by reversibly deactivating the end terminals of TRPV1-expressing primary afferent pain fibers, delivering pain relief that can last months while clearing the body within 24 hours; the FDA granted it Fast Track designation for moderate-to-severe osteoarthritis knee pain. Centrexion runs no developer program and publishes no product API, developer portal, API documentation, SDK or status page. The only machine-readable surface reachable without credentials is the WordPress REST content API behind centrexion.com, catalogued here, together with an llms.txt the site generates for AI crawlers.
Centrexion Therapeutics publishes 10 APIs on the APIs.io network, including Comments API, Custom Types API, Discovery API, and 7 more. Tagged areas include Company, biopharmaceutical, pharmaceuticals, chronic-pain, and non-opioid-analgesics.
Centrexion Therapeutics’ developer surface includes authentication and 20 more developer resources.
Kin Score
APIs 10
Individual APIs this provider publishes, each with its own machine-readable definition.
Centrexion Therapeutics Comments API
Comment collection — one item, the default WordPress sample comment on the placeholder post.
Centrexion Therapeutics Custom Types API
Theme custom post types (`wpex_templates` Dynamic Templates, `wpex_card` Custom Cards). Registered and anonymously reachable, but both report zero published items.
Centrexion Therapeutics Discovery API
Route, type, taxonomy and status discovery documents.
Centrexion Therapeutics Media API
Media library. `X-WP-Total` reports 43 attachments; anonymous enumeration returns fewer (see the listMedia description).
Centrexion Therapeutics Oembed API
oEmbed 1.0 provider endpoint for centrexion.com URLs.
Centrexion Therapeutics Pages API
Corporate pages (6 published at harvest time — Home, Team, Pipeline, Contact, Privacy Policy, Terms of Use).
Centrexion Therapeutics People API
Author records. Anonymously readable on this deployment. Contains personal data — see the operation description; deliberately excluded from the generated Agent Skills.
Centrexion Therapeutics Posts API
The blog/post collection. On this deployment it holds exactly one item — the stock WordPress "Hello world!" placeholder from 2025-07-25. Centrexion publishes no news or press-re...
Centrexion Therapeutics Search API
Cross-content search across published objects (7 searchable objects at harvest time).
Centrexion Therapeutics Taxonomy API
Categories, tags and the post_series taxonomy. Only the default `Uncategorized` category exists; `post_tag` and `post_series` are registered but empty.
Scroll for all 10
Security Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 3
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Other 4
Properties that don't map to a standard resource type